Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,702,054
-
Share change
-
+306,112
-
Total reported value
-
$27,206,222
-
Price per share
-
$10.07
-
Number of holders
-
30
-
Value change
-
+$2,344,234
-
Number of buys
-
19
-
Number of sells
-
9
Institutional Holders of ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) as of Q4 2015
As of 31 Dec 2015,
ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,702,054 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, RA CAPITAL MANAGEMENT, LLC, FEDERATED INVESTORS INC /PA/, Cormorant Asset Management, LLC, EMERALD ADVISERS INC/PA, JPMORGAN CHASE & CO, BlackRock Fund Advisors, VANGUARD GROUP INC, Nationwide Fund Advisors, and STATE STREET CORP.
This page lists
30
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.